LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
11.91
-0.12 (-1.00%)
Oct 1, 2026, 4:00 PM EDT - Market closed

LifeStance Health Group Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, LifeStance Health Group stock has a consensus rating of "Buy" and an average price target of $14.2. The average 1-year stock price forecast is 19.23% higher than the current stock price, while the lowest is $12 (+0.76%) and the highest is $18 (+51.13%).

Price Target: $14.2 (+19.23%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$12$14.2$14$18
Change+0.76%+19.23%+17.55%+51.13%

Analyst Ratings

The average analyst rating for LifeStance Health Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy777777
Buy222222
Hold112222
Sell000000
Strong Sell000000
Total101011111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Jefferies
Jefferies
Buy
Maintains
$14 → $15
BuyMaintains$14 → $15+25.94%Sep 25, 2026
Barclays
Barclays
Buy
Maintains
$13 → $15
BuyMaintains$13 → $15+25.94%Sep 10, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Reiterates
$13 → $15
BuyReiterates$13 → $15+25.94%Sep 9, 2026
William Blair
William Blair
Buy
Reiterates
n/a
BuyReiteratesn/an/aAug 21, 2026
BTIG
BTIG
Buy
Maintains
$16 → $18
BuyMaintains$16 → $18+51.13%Aug 19, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.71B
from 1.42B
Increased by 19.92%
Revenue Next Year
1.95B
from 1.71B
Increased by 14.40%
EPS This Year
0.40
from 0.18
Increased by 116.84%
EPS Next Year
0.53
from 0.40
Increased by 34.19%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
667.51M859.54M1.06B1.25B1.42B1.71B
Revenue Growth
76.96%28.77%22.82%18.50%13.85%19.92%
Gross Profit
201.51M237.02M302.10M402.40M461.10M580.60M
Gross Margin
30.19%27.57%28.62%32.17%32.37%33.99%
Operating Income
-283.76M-205.61M-121.61M-28.87M25.17M95.50M
Net Income
-307.20M-215.56M-186.26M-57.44M9.66M66.39M
EPS
----0.180.40
EPS Growth
----211.64%116.84%
Forward PE
278.81278.81278.81278.81228.5730.11
Free Cash Flow
----110.03M167.72M
No. Analysts
-----10
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High1.7B
Avg1.7B
Low1.7B

Revenue Growth

Revenue Growth202620272028
High
20.8%
Avg
19.9%
Low
19.0%

EPS Forecast

EPS202620272028
High0.54
Avg0.40
Low0.32

EPS Growth

EPS Growth202620272028
High
196.1%
Avg
116.8%
Low
75.4%